# Nuformix investor webinar Wednesday 9th November 2022

- Link: https://www.directorstalkinterviews.com/nuformix-investor-webinar-wednesday-9th-november-2022/4121088867
- Published: 2022-11-04T07:06:04+00:00
- Author: Giles

**Nuformix plc** ([LON:NFX](https://www.directorstalkinterviews.com/company/nuformix-plc/nfx.l)),
a pharmaceutical development company targeting unmet medical needs in fibrosis and
oncology via drug repurposing, has announced that the Company will be hosting an
online presentation and Q&A session at 5.30 p.m. GMT on Wednesday 9 November 2022.
This session is open to all existing and prospective shareholders.  Those who wish
to attend should register via the following link where they will be provided with
access details:

[https://us02web.zoom.us/webinar/register/WN_S2zoC1BuS8KLOVZwAhYHNQ](https://us02web.zoom.us/webinar/register/WN_S2zoC1BuS8KLOVZwAhYHNQ)

Participants will have the opportunity to submit questions during the session, but
questions are welcomed in advance and may be submitted to: nuformix@investor-focus.
co.uk

Nuformix plc is a pharmaceutical development company targeting unmet medical needs
in fibrosis and oncology via drug repurposing. The Company aims to use its expertise
in discovering, developing and patenting novel drug forms, with improved physical
properties, to develop new products in new indications that are, importantly, differentiated
from the original (by way of dosage, delivery route or presentation), thus creating
new and attractive commercial opportunities. Nuformix has a pipeline of pre-clinical
assets with potential for significant value and early licensing opportunities.

Share on:
